diaDexus develops and commercializes patent-protected in vitro diagnostic products addressing significant unmet needs in cardiovascular disease.
The PLAC® Test for Lp-PLA2 is the only blood test cleared by the FDA to aid in assessing risk for both coronary heart disease (CHD) and ischemic stroke associated with atherosclerosis.
